(Press-News.org)
The Ataxia Center at the University Hospital Bonn (UKB) and DZNE have been awarded the title “Ataxia Center of Excellence” by the US National Ataxia Foundation (NAF) for their patient care and research – as the only organization in Europe. The foundation represents patient interests and is one of the world’s major non-governmental funders of ataxia research. These rare brain diseases are characterized by progressive loss of balance and coordination, accompanied by slurred speech. It is estimated that this condition affects around 16,000 women and men in Germany.
The NAF awarded the title “Ataxia Center of Excellence” to 19 hospitals and institutes worldwide. The quality of patient care and clinical research were evaluated. Only four organizations are located outside the United States. The tandem of UKB and DZNE is the only honored institution in Europe. “This is a great recognition for the work of our entire team,” says Dr. Jennifer Faber, deputy director of the Ataxia Center at UKB and research associate at DZNE. “With outpatient and inpatient treatment as well as interdisciplinary conferences, we offer a comprehensive range of services specifically for patients with ataxias. The close interaction of patient care and research at our site is exceptional and outstanding.”
Care and Research
For years, Bonn has been a recommended center for the care of people with ataxias and a driving force in ataxia research. More than 250 patients attend the Ataxia Center of the UKB every year. Often, their health development is followed by the Bonn experts for years. In addition, the team led by Prof. Thomas Klockgether – who is also Director of Clinical Research at DZNE and Director of the Department of Neurology at UKB – is running various clinical observational and interventional studies. A European network for research in hereditary ataxias is coordinated from Bonn. More than 150 of the patients participate in study visits at DZNE each year, and thus supporting research in the field of theses rare diseases.
Science and Perspectives
Up to now, there is no cure for ataxias. All ataxia show amongst other neurodegeneration pathological alterations and consecutive dysfunction of the cerebellum. As a result, power and metric of movements is impaired. Common symptoms are gait disturbances, impaired balance and slurred speech. Physiotherapy has a positive effect on symptoms – but it is only a symptomatic treatment and does not address the causes. However, Thomas Klockgether has hopes that it might be possible to tackle at least some forms of ataxia at their roots. “The pharmaceutical industry has developed experimental compounds that target disease-relevant genes. We are in talks with the manufacturers to participate in testing these substances. Such trials require large and well-characterized groups of patients. We have built up such study cohorts over many years. For pharmaceutical companies, this qualifies us a scientific partner,” Klockgether says.
One focus of ataxia research in Bonn is to investigate pathological changes in the cerebellum occurring early in the course of the disease by using magnetic resonance imaging. “As part of our research, we identify structural alterations in the cerebellum that are measurable long before the onset of symptoms, such as gait disturbances,” explains Jennifer Faber. “If effective gene therapies become available in the future, such findings will allow interventions even before the onset of symptoms. We hope that such early treatments have the potential to, if not prevent, at least delay the onset of ataxia.”
More Information
https://www.ataxia.org/ACE (Ataxia Centers of Excellence, NAF)
https://neurologie.uni-bonn.de/schwerpunkte/ataxien (UKB's Ataxia Center, German)
https://www.dzne.de/en/news/background/ataxia/ (About ataxias)
About the Deutsches Zentrum für Neurodegenerative Erkrankungen, DZNE (German Center for Neurodegenerative Diseases): DZNE is a research institute funded by the German federal and state governments, comprising ten sites across Germany. It is dedicated to diseases of the brain and nervous system, such as Alzheimer’s, Parkinson’s, and ALS, which are associated with dementia, movement disorders and other serious health impairments. To date, there are no cures for these diseases, which represent an enormous burden for countless affected individuals, their families, and the healthcare system. The aim of DZNE is to develop novel strategies for prevention, diagnosis, care, as well as treatment, and to transfer them into practice. To this end, DZNE cooperates with universities, university hospitals, research centers and other institutions in Germany and abroad. The institute is a member of the Helmholtz Association and belongs to the German Centers for Health Research. www.dzne.de/en
About the University Hospital Bonn: The UKB cares for about 500,000 patients per year, employs 9,000 people and has a balance sheet total of 1.6 billion euros. In addition to the more than 3,300 medical and dental students, a further 585 people are trained each year in numerous healthcare professions. The UKB is ranked number one among university hospitals in NRW in the science ranking as well as in the Focus clinic list and has the third highest case mix index (case severity index) in Germany. www.ukbonn.de/patient_innen/international/english
END
Copenhagen, Denmark: More than three months after suffering from mild COVID infection, men have lower sperm concentrations and fewer sperm that are able to swim, according to new findings presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1].
Professor Rocio Núñez-Calonge, scientific advisor at UR International Group at the Scientific Reproduction Unit, Madrid (Spain), said that after an average of 100 days following SARS-CoV-2 infection there appeared to be no improvement in sperm quality ...
Copenhagen, Denmark: A small study with couples experiencing unexplained infertility suggests that a hormone treatment could increase the chances of having a baby.
The trial, presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1], compared couples trying to conceive naturally with couples where the woman used a vaginal progesterone treatment during the second half of her menstrual cycle.
The researchers say a larger trial is now warranted but, given the treatment is safe and low-cost, it could ultimately benefit many people living with infertility around the world.
The study ...
CHAMPAIGN, Ill. — 50 million years ago in what is now northwestern Colorado, a katydid died, sank to the bottom of a lake and was quickly buried in fine sediments, where it remained until its compressed fossil was recovered in recent years. When researchers examined the fossil under a microscope, they saw that not only had many of the insect’s hard structures been preserved in the compressed shale, so had several internal organs and tissues, which are not normally fossilized.
They describe their findings in the journal Palaeoentomology.
“Katydids ...
Copenhagen, Denmark: Women are just as likely to give birth to live babies after fertility treatment if embryos are transferred to their wombs three days after fertilisation in the laboratory rather than five. However, the women’s age can affect the outcomes, according to new research presented to the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1].
Dr Simone Cornelisse, a researcher and resident in obstetrics and gynaecology at Radboud University Medical Center, Nijmegen (The Netherlands), told the conference that among 1202 women from 21 Dutch fertility centres who were randomly assigned to have embryos transferred to their wombs ...
Copenhagen, Denmark: Women with polycystic ovary syndrome (PCOS) are not at any greater risk of ovarian cancer than those without the common hormone condition, say researchers. However, those with PCOS who have been through the menopause are more than twice as likely to be diagnosed with ovarian cancer.
The data based on nearly two million women is presented today (Monday) at the 39th annual meeting of the European Society of Human Reproduction and Embryology (ESHRE) [1]. The research is also published simultaneously in the International Journal of Cancer [2].
This ...
Researchers from the Smithsonian’s National Museum of Natural History have identified the oldest decisive evidence of humans’ close evolutionary relatives butchering and likely eating one another.
In a new study published today, June 26, in Scientific Reports, National Museum of Natural History paleoanthropologist Briana Pobiner and her co-authors describe nine cut marks on a 1.45 million-year-old left shin bone from a relative of Homo sapiens found in northern Kenya. Analysis of 3D models of the fossil’s surface revealed ...
Scientists led by Sabine Taschner-Mandl, PhD, St. Anna Children's Cancer Research Institute, and Nikolaus Fortelny, PhD, Paris Lodron University of Salzburg, are the first to analyze bone marrow metastases from childhood tumors of the nervous system using modern single-cell sequencing analysis. It turns out that cancer cells prevent cells in their environment from fighting the tumor – a process that could be reversed with medication. The findings were published in the renowned journal Nature Communications.
Neuroblastoma is the most ...
For many patients with hypertension—an elevated blood pressure that can lead to stroke or heart attack—medication keeps the condition at bay. But what happens when medication that physicians usually prescribe doesn’t work? Known as apparent resistant hypertension (aRH), this form of high blood pressure requires more medication and medical management.
Novel research from investigators in the Smidt Heart Institute at Cedars-Sinai, published today in the peer-reviewed journal Hypertension, found that aRH prevalence was lower in ...
New controlled trial research documents that Progesterone (micronized, oral) is effective at decreasing night sweats and improving sleep in perimenopausal women who have menstruated in the last 1-year. Perimenopausal women most want treatment for these two symptoms.
Current guidelines prescribe Menopausal Hormone Therapy (MHT) for disturbing hot flushes/flashes or night sweats (vasomotor symptoms, VMS) in all women younger than 60 years.
“This guideline assumes that hormone levels and symptoms are the same in the early years of ...
Study reveals some distinctions between Black women in the US and the French Caribbean but increasing trends for aggressive forms in both regions.
Compared with white women, Black women have elevated risks of being diagnosed with advanced uterine cancer—also known as endometrial cancer—and of developing aggressive tumors. Researchers recently compared the incidence and trends for endometrial cancer, both overall and by subtype, between African descent women in Florida and women in the French Caribbean—specifically, the islands of Martinique and Guadeloupe. The findings are published by Wiley online ...
